| PUBCHEM ID |
76971996
|
| UNII |
75U66GGS06
|
| Preferred Term |
GUTTIFERONE F
|
| CAS |
219538-86-0
|
| INCHIKEY |
QDKLRKZQSOQWJQ-LPEHXNHASA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CC(C)([C@@H](CC=C(C)C)C[C@](C[C@H](CC=C(C)C)C(C)=C)(C1=O)C(/C2=C(\c(cc3)cc(O)c3O)/O)=O)[C@]1(CC=C(C)C)/C2=O
|
| Total Surface Area |
473,73
|
| Relative PSA |
0,16554
|
| TPSA |
111,9
|
| cLogS |
-6,119
|
| MW |
602,809
|
| cLogP |
9,5526
|
| H-Acceptors |
6
|
| H-Donors |
3
|
| Ro5 violations |
2
|
| Druglikeness |
-19,685
|
| DrugScore |
0,096449027246154
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2+
|
| Caco-2 Permeability II |
0,8046
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Inhibitor
|
| CYP450 2C9 Inhibitor |
Inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
-1,0219
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
1,7011
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,5859
|
| Carcinogenicity (Three-class) |
Non-required
|
